Brazilian Journal of Analytical Chemistry · 2021 · 20 citations · 90 references
PharmacyToxicologyDrug LawForensic ToxicologySubstance Use DisordersConfirmatory TestingDrug IdentificationDrug TraffickingDrugs Of AbuseNovel Psychoactive SubstancesSubstance UseConfirmatory Toxicological TestingIllicit Drug DetectionIllicit Drug IdentificationIllicit Synthetic CannabinoidsNew Psychoactive Substances IdentificationNovel Psychoactive Substance DetectionSynthetic Opioids
Correct identification of substances is essential to understand drug use and trafficking trends and guide measures for harm reduction and treatment. Two steps are needed to verify the nature of a substance properly: a presumptive test and a confirmatory test. There are presumptive tests which presents deficiencies, such as providing false-positive and false-negative results. Confirmatory tests are more reliable, but they are more expensive. With the appearance of New Psychoactive Substances (NPS), identifying and characterizing illicit substances has become more challenging. This paper focuses on presenting information about NPS characteristics and analysis. For this purpose, we have reviewed the literature to address the main aspects of five groups of NPS: amphetamine-type stimulants, synthetic cannabinoids, N-methoxybenzyl-methoxyphenylethylamine (NBOMe), synthetic opioids, and benzodiazepines. We present the main characteristics of each group and certain aspects of presumptive and confirmatory tests regarding these groups. Our findings show obstacles in developing methodologies that can correctly identify these substances, and problems can increase as new structures appear. This information can be helpful to drive research into identifying NPS and inform law enforcement and law practitioners about the main characteristics of each group and the main questions involving their identification.
90
Drug harms in the UK: a multicriteria decision analysis
David Nutt, Leslie A. King, Lawrence D. Phillips · The Lancet · 2010 · 1.7K citations